Feds revisit mammography guidelines

Share this content:
Feds revisit mammography guidelines for women
Feds revisit mammography guidelines for women

HealthDay News — Female patients aged 40 years or older should talk with their health-care providers and then decide for themselves whether they need regular mammograms to screen for breast cancer before age 50 years, according to draft United States federal health guidelines.

The draft mammography guidelines issued by the U.S. Preventive Services Task Force (USPSTF) largely reiterate those that have been in place since 2009, the last time they were updated. The guidelines still recommend mammograms to screen for breast cancer every two years for women aged 50 to 74 years.

In the proposed USPSTF update, the task force emphasized that women in their 40s should make a decision whether or not to receive mammograms every two years after talking about their individual risk factors with their providers. In the report, the task force also showed that the harms associated with mammography steadily decrease with age.

For example, there are more than 1,200 false positives for every 10,000 women who undergo mammography in their 40s; by their 50s, the false positive rate declines to over 900 per 10,000 women, and even further down to just over 800 per 10,000 for women in their 60s.

In its updated guidelines, the USPSTF also said it was unable to make a recommendation for or against the value of three-dimensional mammography screening, because there is not enough evidence to show whether it will save more lives and improve women's health.

The task force also couldn't say, based on the evidence available, whether additional screening tools like ultrasound or magnetic resonance imaging could help women with dense breasts screen for cancer. Dense breasts are difficult to screen with standard mammography, and women with dense breasts are at increased risk of breast cancer. The task force called for more research in both areas.

The public has until May 18 to comment on the draft guidelines.

You must be a registered member of Clinical Advisor to post a comment.

Sign Up for Free e-newsletters